Related Experiment Videos
Quisqualate resolves two distinct metabotropic [3H]glutamate binding sites
M V Catania1, Z Hollingsworth, J B Penney
1Neurology Service, Massachusetts General Hospital, Boston 02114.
Neuroreport
|March 1, 1993
Summary
This study identified two distinct metabotropic glutamate receptor binding sites in rat brains using [3H]glutamate autoradiography. These findings reveal unique distributions and pharmacological profiles for these receptor subtypes.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Metabotropic glutamate receptors (mGluRs) are crucial for synaptic plasticity and neurotransmission.
- Evidence suggests the existence of mGluR subtypes based on various molecular and signaling data.
Purpose of the Study:
- To investigate potential metabotropic binding site subtypes.
- To characterize their distribution and pharmacological properties in the adult rat brain.
Main Methods:
- In vitro quantitative [3H]glutamate autoradiography was employed.
- Competition binding assays were performed using quisqualate (QUIS), N-methyl-D-aspartate (NMDA), and alpha-amino-3-hydroxy-5-methyl-4-isoxazoleproprionate (AMPA).
- The effects of trans-1-amino-cyclopentane-1,3-dicarboxylic acid (t-ACPD) and 1S,3R-ACPD were assessed.
Main Results:
- Quisqualate competition curves revealed two differentially distributed binding sites with high (KI = 17 nM) and low (KI = 62 µM) affinities.
- Both sites were shown to be linked to metabotropic receptors, as indicated by displacement assays with t-ACPD and 1S,3R-ACPD.
- These two sites exhibited distinct regional distributions within the brain.
Conclusions:
- Two metabotropic glutamate receptor binding sites with differing pharmacological profiles and distributions can be identified using selective [3H]glutamate binding assays.
- This provides a basis for further understanding the functional roles of mGluR subtypes in the central nervous system.